Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura
- PMID: 20807984
- PMCID: PMC2930942
- DOI: 10.3324/haematol.2010.027169
Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura
Comment on
-
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.Haematologica. 2010 Sep;95(9):1555-62. doi: 10.3324/haematol.2009.019299. Epub 2010 Apr 7. Haematologica. 2010. PMID: 20378566 Free PMC article.
References
-
- Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc. 1924;24:21–4.
-
- Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, et al. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;307(23):1432–5. - PubMed
-
- Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347 (8):589–600. - PubMed
-
- Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89:3097–103. - PubMed
-
- Gerritsen HE, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001;98(9):1654–61. - PubMed
